Home
>
National Drug Code (NDC)
>
JALYN
JALYN - 0173-0809-13 - (dutasteride and tamsulosin hydrochloride)
Drug Information of JALYN
| Product NDC: | 0173-0809 |
| Proprietary Name: | JALYN |
| Non Proprietary Name: | dutasteride and tamsulosin hydrochloride |
| Active Ingredient(s): | .5; .4 mg/1; mg/1 & nbsp; dutasteride and tamsulosin hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of JALYN
| Product NDC: | 0173-0809 |
| Labeler Name: | GlaxoSmithKline LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022460 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20100621 |
Package Information of JALYN
| Package NDC: | 0173-0809-13 |
| Package Description: | 30 CAPSULE in 1 BOTTLE (0173-0809-13) |
NDC Information of JALYN
| NDC Code | 0173-0809-13 |
| Proprietary Name | JALYN |
| Package Description | 30 CAPSULE in 1 BOTTLE (0173-0809-13) |
| Product NDC | 0173-0809 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | dutasteride and tamsulosin hydrochloride |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20100621 |
| Marketing Category Name | NDA |
| Labeler Name | GlaxoSmithKline LLC |
| Substance Name | DUTASTERIDE; TAMSULOSIN HYDROCHLORIDE |
| Strength Number | .5; .4 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes | 5-alpha Reductase Inhibitor [EPC],5-alpha Reductase Inhibitors [MoA],Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC] |
